Drug Manufacturing is the method through which Pharmaceutical Companies create medications on an industrial scale. The processes used to make drugs may be divided into a number of unit operations. The procedure may include milling, granulation, coating, and tablet pressing. The pharmaceutical sector is a crucial part of the global health care infrastructure. It is made up of businesses that are both public and private that find, develop, produce, and sell medications. The creation of medications that either prevent or treat illnesses and disorders is the mainstay of the Pharmaceutical Business. The creation and spread of novel medications with greater therapeutic effectiveness and fewer side effects is accelerating because to contemporary scientific and technical advancements. Increased potency and specificity of medications is a goal shared by medicinal chemists, molecular biologists, and pharmacists. The method through which pharmaceutical corporations create pharmaceuticals on an industrial scale is known as drug manufacturing. A number of unit activities make up the processes used to make drugs. Possible steps in the process include milling, granulating, coating, and tablet pressing.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico